Dr. Rosanna Squitti

Dr. R. Squitti’s research focuses on metal involvement in metabolic, neurological, and psychiatric illnesses. She was the first to discover that the fraction of serum copper not bound to ceruloplasmin, referred to Non-Ceruloplasmin copper (or ‘free’ or ‘labile’ copper; two patents) is a risk factor for Alzheimer’s disease (Squitti et al, Neurol 2002, 2003, 2005, 2006, 2009; Squitti et al Ann Neurol 2014; Squitti et al Biomolecules 2021), and that the ATP7B - the gene that controls copper excretion and whose mutations cause Wilson's disease - is also a susceptibility gene for Alzheimer's disease (Squitti et al, J Alzheimer’s Dis. 2021; Squitti et al, Metallomics 2016). She is a World's top 2% scientists (https://doi.org/10.17632/btchxktzyw.1) and the author of more than 140 peer-reviewed papers, ORCID (http://orcid.org/0000-0002-5624-1140, whose citations you can track at Rosanna Squitti Google Scholar – H index 49 Rosanna Squitti Scopus – H index 43, citations (Google Scholar) 7038